UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | January 5, 2007 |
Clearant, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware | 000-50309 | 912190195 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
11111 Santa Monica Blvd., Suite 650, Los Angeles, California | 90025 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | (310) 479-4570 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.02 Termination of a Material Definitive Agreement.
On January 3, 2007, Clearant, Inc. received a Notice of Termination from Cryolife, Inc. to terminate the December 12, 2003, License Agreement, effective January 31, 2007. CryoLife cited the reason for the termination to be their discontinuation of some of their orthopedic activities as of January 1, 2007. CryoLife has agreed to immediately pay Clearant the $100,000 termination fee and any outstanding license royalties.
Unless otherwise required by law, Clearant disclaims any obligation to release publicly any updates or any changes in its expectations or any change in events, conditions, or circumstances on which any forward-looking statements are based.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Clearant, Inc. | ||||
January 5, 2007 | By: |
/s/ ALAIN DELONGCHAMP
|
||
|
||||
Name: ALAIN DELONGCHAMP | ||||
Title: Chief Executive Officer |